The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Eton Pharmaceuticals Inc shares valued at $267,375 were purchased by Opaleye Management Inc. on Sep 10 ’24. At $4.65 per share, Opaleye Management Inc. acquired 57,500 shares. The insider’s holdings grew to 2,660,000 shares worth approximately $18.38 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Opaleye Management Inc. purchased 50,000 shares, netting a total of over 237,500 in proceeds. Following the buying of shares at $4.75 each, the insider now holds 2,705,000 shares.
Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. Earlier on January 04, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for ETON stock.
Analyzing ETON Stock Performance
During the last five days, there has been a surge of approximately 21.65%. Over the course of the year, Eton Pharmaceuticals Inc shares have jumped approximately 57.76%. Shares of the company reached a 52-week high of $6.92 on 10/03/24 and a 52-week low of $3.03 on 04/17/24. A 50-day SMA is recorded $4.62, while a 200-day SMA reached $4.09. Nevertheless, trading volume fell to 0.73 million shares from 56300.0 shares the previous day.
Support And Resistance Levels for Eton Pharmaceuticals Inc (ETON)
According to the 24-hour chart, there is a support level at 6.30, which, if violated, would cause prices to drop to 5.69. In the upper region, resistance lies at 7.22. The next price resistance is at 7.53. RSI (Relative Strength Index) is 80.66 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.41, which suggests the price will decrease in the coming days. Percent R is at 0.57%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Eton Pharmaceuticals Inc (ETON)?
On September 20, 2019, B. Riley FBR assigned a price target of “a Buy” to the stock and initiated coverage with a $13.50.
